News
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
Pfizer faces weak growth, sector headwinds, and pipeline uncertainty despite cost cuts and a 7% yield, weighing on sentiment.
Shares of Pfizer Inc. PFE slid 2.18% to $23.29 Thursday, on what proved to be an all-around dismal trading session for the ...
A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid shot data to hurt Donald Trump’s 2020 election prospects, the latest twist ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pfizer CEO Albert Bourla is expected to attend a $25 million fundraiser at US President Donald Trump’s golf club in ...
I can’t ask you to do that because we are still on the verge of finding out what the Seagen acquisition does. Let’s give Dr.
4d
Barchart on MSNPfizer Stock: Analyst Estimates & Ratings
Pfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the ...
For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...
Pfizer Inc and BioNTech's vaccine was 73.2% effective in preventing COVID-19 among children aged 6 months through 4 years, new data from the companies showed on Tuesday, two months after the U.S ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is set to launch a pivotal Phase 3 clinical study titled ‘A ...
This was the stock's third consecutive day of losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results